top of page
About us

Orthogen AG and its Members

The biotech research company was founded in 1993 and employs around 20 people with various scientific qualifications and experiences. Orthogen AG is a privately held Holdings Company located in Dusseldorf, Germany where its founder and CEO,
Prof. (USA) Dr. Peter Wehling and his management team reside.


Part of our core competency is creating molecular/biological insights, patenting those discoveries and technologies and bringing these to patients in need.

Management Team

Peter Wehling CEO of Orthogen

Peter Wehling, MD, PhD

CEO and Founder of Orthogen AG

  • Pioneer in the field of Regenerative Medicine and Molecular Orthopedics

  • Specialist in orthopedics and sports medicine with focus on the treatment of chronic pain and care of top athletes

  • Member of the medical faculty at Heinrich-Heine-University Düsseldorf, Germany, and Professor adj. at Duke University, NC, USA


Julio Reinecke, PhD

CSO and Co-Founder of Orthogen AG

  • established laboratory and production infrastructure as well as biotechnology methods 

  • Research focus on autologous biologic treatments and local inflammatory conditions such as Osteoarthritis

Supervisory Board


Christopher Evans, PhD

Chairman of the Supervisory Board

  • Professor of Orthopedic Surgery Emeritus at Harvard Medical School

  • Director of the Rehabilitation Medicine Research Center at the Mayo Clinic

  • Research focus on treatment of arthritis 


Simone Sandkühler, PhD

Member of the Supervisory Board

  • Senior manager at KPMG Advisory in Management Consulting

  • Former management consultant at Boston Consulting Group

  • PhD in Neuroscience, University of Vienna

gary photo 1.jpg

Gary Tobey

Member of the Supervisory Board

  • CEO and Chairman of Haworth Marketing + Media

  • developed top level executive relationships in the Media, Entertainment and Sports industries

Strategic Advisors


Michael Hamilton

Consultant Strategy Projects for Orthogen AG

  • Managing Director of Triangle BioVentures

  • Former VP, global commercial strategy (infectious diseases) and former VP, global product strategy (neuroscience) at GlaxoSmithKline

  • Former CEO of ALG Therapeutics


Klaus Wehling

Legal Consultant for Orthogen AG

  • Co-Founder of Orthogen AG

  • CFO of Orthogen AG for 20 years (until the end of 2020)

  • Consultant for legal and commercial matters

In Honor


William Maixner, DDS, PhD

Former Member of the Supervisory Board
deceased on Nov 2nd, 2020

  • Former President of the American Pain Society

  • Director Innovative Pain Therapies at Duke University

  • Co-Director of the Center for Translational Pain Medicine (CTPM) at Duke University

Get an insight into our office spaces and laboratories in the heart of Düsseldorf, Germany.

bottom of page